Pagani F, Zecca M, Giachetti A
Department of Pharmacology, Istituto De Angeli, Milan, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):349-51. doi: 10.1007/BF00172689.
The H2-receptor antagonists mifentidine and cimetidine were compared for their ability to antagonize the activation of H2-receptors in the conscious dog. Dose-response curves to dimaprit in stimulating gastric secretion were displaced to the right in a dose-related fashion by both drugs. Schild and Eadie-Hofstee analysis of these data indicated that mifentidine and cimetidine inhibited in vivo activation of H2-receptors in a manner compatible with competitive surmountable antagonism. Mifentidine displayed a 24fold greater potency than cimetidine as H2 antagonist in the conscious dog.
比较了H2受体拮抗剂米芬替丁和西咪替丁对清醒犬体内H2受体激活的拮抗能力。两种药物均以剂量相关的方式使对二甲双胍刺激胃酸分泌的剂量-反应曲线右移。对这些数据进行的Schild和Eadie-Hofstee分析表明,米芬替丁和西咪替丁以与竞争性可逆拮抗作用相符的方式抑制体内H2受体的激活。在清醒犬中,米芬替丁作为H2拮抗剂的效力比西咪替丁高24倍。